Company profile: Ancora Heart
1.1 - Company Overview
Company description
- Provider of the AccuCinch Ventricular Restoration System, a minimally invasive therapy for heart failure patients with reduced ejection fraction, aiming to reduce the size of the left ventricle and support its wall, and the CORCINCH-HF clinical study evaluating the safety and efficacy of AccuCinch in patients with symptomatic heart failure and reduced ejection fraction.
Products and services
- AccuCinch Ventricular Restoration System: A minimally invasive therapy engineered for heart failure with reduced ejection fraction that reduces the size of the left ventricle and supports its wall
- CORCINCH-HF Study: A clinical trial evaluating the safety and efficacy of the AccuCinch System in patients with symptomatic heart failure and reduced ejection fraction
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ancora Heart
MC3 Cardiopulmonary
HQ: United States
Website
- Description: Provider of cardiopulmonary devices, including the Nautilus Smart ECMO module for extracorporeal life support with blood oxygenation, CO2 removal, and temperature regulation via integrated sensors and touch-screen monitoring; the Crescent Jugular Dual Lumen Catheter for V-V ECMO in acute respiratory failure; and the Soft-Flow Arterial Cannula for gentle aortic perfusion, distributed globally by Medtronic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MC3 Cardiopulmonary company profile →
Avenu Medical
HQ: United States
Website
- Description: Provider of the Ellipsys Vascular Access System, a minimally invasive solution for creating arteriovenous fistulas in hemodialysis patients, using thermal energy to fuse tissue without leaving foreign materials, pursuing unmet clinical needs with cost-effective, efficient approaches to vascular access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avenu Medical company profile →
Mortara
HQ: United States
Website
- Description: Provider of electrocardiography (ECG) products designed to meet clinical needs with simplicity and economic accessibility, delivering value without performance compromise for today's healthcare market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mortara company profile →
Baylis Medical
HQ: Canada
Website
- Description: Provider of high-technology cardiology, endovascular, and oncology products, specializing in RF transseptal access and puncture systems that create controlled perforations in cardiac and vascular tissues. Products include NRG RF Transseptal Kit and Needle, SupraCross RF Transseptal Solution, VersaCross steerable access solutions, and SureFlex steerable guiding sheaths.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baylis Medical company profile →
SynCardia
HQ: United States
Website
- Description: Provider of total artificial heart technology, including the SynCardia temporary Total Artificial Heart used as a bridge to heart transplantation for patients with end-stage biventricular heart failure. Offers 70cc and 50cc biventricular replacement devices, the latter for patients of smaller stature, and is developing a Next Generation Total Artificial Heart.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SynCardia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ancora Heart
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ancora Heart
2.2 - Growth funds investing in similar companies to Ancora Heart
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ancora Heart
4.2 - Public trading comparable groups for Ancora Heart
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →